Patents
Peaches Biotech Group registered patents.
At the service of health and biotechnology
At Peaches Biotech, we develop innovative biotechnology solutions based on patents developed in our R&D Department with the aim of generating new biological medicines for tissue regeneration and, therefore, improving health and quality of life.
Patent_ Tissue-Specific Growth Factors, Method of Production and Uses Thereof
A pioneering method for producing tissue-specific growth factors capable of regenerating damaged tissue. Approved by the European Patent Office and validated in more than 25 countries.
TECHNOLOGICAL ADVANTAGES:
- Production of tissue-specific growth factors.
- Possibility of prolonged storage without loss of biological activity.
- Versatile application in human and veterinary medicine.
APPLICATIONS:
Tendinosis, muscle tears, tendinitis, bursitis, osteoarthritis, neurological injuries, ulcers, skin regeneration, among others.
Patent_ Composition for
Tissue Regeneration
Advanced technology that uses M2 macrophages and tissue-specific cells to create biological compositions that stimulate targeted regeneration. Currently under review in Europe, America, and Asia.
TECHNOLOGICAL ADVANTAGES:
- Sterile, cell-free solutions suitable for cryopreservation or lyophilisation.
- Maintain biological activity after long periods of storage.
- Potential autologous or allogeneic use.
APPLICATIONS:
Muscle, tendon or joint injuries, ulcers, osteoarthritis, neurological, respiratory or skin injuries.
Licensed patent_ Granulisina
Exclusive licence for a patent from the University of Zaragoza. This development is part of the line of immunology-based drug generation for the treatment of solid tumours, especially colon tumours, expanding the therapeutic scope of Peaches S.L.’s portfolio.
Global Presence
Patents protected in Europe, America, Asia and Oceania, consolidating Peaches S.L. as a leading player in the international field of regenerative medicine.
Biotechnology innovation portfolio:
- 2 proprietary patents under PRS technology.
- 1 exclusively licensed patent (University of Zaragoza).
- Presence and protection in Europe, America, Asia and Oceania.
- 2 lines of research in advanced immunological therapies: tissue regeneration immunology and oncological immunology
- Focus on biological medicines for tissue regeneration and personalised medicine.
SCIENCE
TECHNOLOGY
LOCATION
C/ Isabel Colbrand 6
4ª Planta B
28050 Madrid (Spain)
OPENING HOURS
L - J : 9:00–18:00 hs
V : 9:00–15:00 hs